Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
II-VI’s thermoelectrics for air-to-air or air-to-cold-plate heat exchanger systems allow for immunoassay reagent cooling, in vitro diagnostic specimen temperature control, genome sequencing reagent cooling, genome sequencing temperature cycling of sample slides, DNA fluidic sample temperature cycling, and general cooling units for the storage and transportation of insulin, tissue, and human organs. The TECs are quiet, with no moving parts; operate on low-voltage DC; and can be sealed to meet required sanitary specifications. This versatility enables precise temperature control of the cold plate or cold-side air stream and can provide both heating and cooling by simply switching the polarity of the DC voltage.![]()
We are an ISO 9001-13485-14001-45001 and IATF 16949 certified company with a very experienced, outstanding technical team that can do extensive thermal and electrical modeling and analysis hand-in-hand with our customers
Share this Article:
Tweet
|
Company
II-VI
Headquarters
Dallas, Texas, USA
Management
Peter Townsend, General Manager
Description
II-VI Incorporated (pronounced “two-six”) designs and manufactures tailor-made solutions and services for customers looking to solve their complex thermal challenges while delivering best-in-class quality, performance, and low-cost efficiency. II-VI offers thermoelectric coolers (TECs) that are customized for each client’s application size, weight, and electrical power requirements while providing reliable thermal performance. The company has specifically formulated and developed a family of thermoelectric materials to address new demands in key scientific fields, such as biotechnology and medical instrumentation
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info